Agendia to Showcase New Research on AI-Driven Digital Pathology at ESMO 2026

Agendia, Inc., a leader in precision oncology for breast cancer, announced today that it will present new research during a podium presentation on the development of an artificial intelligence (AI)-driven digital pathology approach for MammaPrintⓇat the European Society for Medical Oncology (ESMO) Congress 2026, which takes place October 23 to 27, 2026...
Anglais